The Wilder lab aims to prevent immune-mediated adverse side effects associated with cytokine therapy by understanding innate immune regulation and developing dynamically controlled therapies.
The Shy Lab employs cutting-edge genome and epigenome engineering techniques to address the current limitations in cell therapy development, manufacture, and delivery.
At the Nicolas-Avila Lab, we explore the mechanisms by which immune cells contribute to tissue function and develop strategies to improve organismal health through immunomodulation.